(4-Amino-2-(methylthio)thiazol-5-yl)(2-nitrophenyl)methanone, 97%, 250mg

iScope IS.1153-PLi/DFi Triocular with Plan IOS objectives and Rackless cross stage (dark field contrast application)

2-Chloro-5-(4-fluorophenyl)oxazole, 250mg

4-Methoxy-1-naphthol>98.0%(GC)25g

tert-Butyl (2-aminoethyl)(ethyl)carbamate, 95.0%, 25g

3-Ethoxysalicylaldehyde>97.0%(GC)25g

4-CHLORO-N,6-DIMETHYL-1,3,5-TRIAZIN-2-AMINE, 95.0%, 250mg

4-Methyl-5-thiazolemethanamine, 95.0%, 5g

Tetramethylammonium acetate, 97.0%, 25g

[3-(4-chlorophenyl)oxetan-3-yl]methanol, 95.0%, 1g

2-(P-tolyl)butanoic acid, 95%, 2.5g

(2E)-3-(3-fluorophenyl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

2-(2-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene, 97%, 10mg